Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed CFO

NANOVIRICIDES, INC. (NNVC) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 10-K Annual Report for the period ended June 30, 2023
09/28/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
05/25/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "PLAN OF CONVERSION OF NANOVIRICIDES, INC."
05/23/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
05/05/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/31/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "LICENSE AGREEMENT THIS LICENSE AGREEMENT is made at Kolhapur on March 10, 2023 by and Between NANOVIRICIDES, INC. a Company incorporated under the laws of the State of Nevada, and having its registered office at 1 Controls Drive, Shelton, CT 06484 and its successors and assigns with offices And M/S KARVEER MEDITECH PRIVATE LIMITED a company incorporated under Companies Act, 2013 and having it registered office at plot No. 34, Vijaya Nagar, Near Shahu Naka, Ujalaiwadi, Kolhapur, Taluka-Karveer, District-Kolhapur, Maharashtra, India 416004 and its successors and assigns and all of whom are at times referred to as the "Parties". WHEREAS, Karveer is engaged in conducting research and development in the fields of pharmaceuticals and related activities, and has the necessary skill, experience, e..."
02/14/2023 10-Q Quarterly Report for the period ended December 31, 2022
02/13/2023 8-K Quarterly results
12/22/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/22/2022 8-K Submission of Matters to a Vote of Security Holders, Other Events  Interactive Data
11/15/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/04/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
10/13/2022 10-K Annual Report for the period ended June 30, 2022
10/11/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EXTENSION TO EMPLOYMENT AGREEMENT This Extension to Employment Agreement effective as of July 1, 2022, between ANIL R. DIWAN, c/o NanoViricides, Inc., 1 Controls Drive, Shelton, CT 06484 , and NanoViricides, Inc., a corporation with offices at 1 Controls Drive, Shelton, CT 06484 . WHEREAS, the Parties entered into that certain Employment Agreement on July 11, 2018 which expired pursuant to its terms on June 30, 2021 which was subsequently extended to June 30, 2022 ; WHEREAS, the parties hereto desire to extend the term of the Employment Agreement and to add to and/or revise the terms and conditions of the Employment Agreement; and WHEREAS, the Parties hereto desire that all other terms and conditions of the Employment Agreement not specifically amended hereby will remain in full force and ..."
09/29/2022 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
08/10/2022 4 Diwan Anil (President) has filed a Form 4 on NANOVIRICIDES, INC.
Txns: Gifted 94,471 shares @ $0
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
02/14/2022 10-Q Quarterly Report for the period ended December 31, 2021
11/26/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
10/12/2021 10-K Annual Report for the period ended June 30, 2021
10/12/2021 DEF 14A Form DEF 14A - Other definitive proxy statements:
09/28/2021 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
09/21/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Draft Information Document"
09/15/2021 8-K Quarterly results
05/14/2021 10-Q Quarterly Report for the period ended March 31, 2021
02/16/2021 10-Q Quarterly Report for the period ended December 31, 2020
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/26/2021 SC 13G/A Empery Asset Management, LP reports a 0% stake in NanoViricides, Inc.
01/04/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/10/2020 8-K Submission of Matters to a Vote of Security Holders
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy